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        Introduction 
  c-Fos is a member of the dimeric activator protein 1 (AP-1) tran-
scription factor family that regulates key cellular processes, 
including cell proliferation, death, survival differentiation, and 
oncogenic transformation (  Shaulian and Karin, 2002  ;   Eferl and 
Wagner, 2003  ).   c-fos   is an   “  early response  ”   gene that undergoes 
rapid transcriptional activation in response to multiple patho-
physiological stimuli (e.g., growth factors, chemical and physi-
cal stress, etc.) (  Shaulian and Karin, 2002  ). Fine regulation of 
c-Fos activity is achieved via its interaction with regulatory pro-
teins that can either enhance or inhibit AP-1 activity, and through 
posttranslational processing of preexisting or newly synthesized 
c-Fos protein (  Piechaczyk and Blanchard, 1994  ;   Shaulian and 
Karin, 2002  ). For example, c-Fos can be phosphorylated by pro-
tein kinases C and A, cdc2 (  Abate et al., 1991  ), FRK (  Deng and 
Karin, 1994  ), extracellular signal-regulated kinase 7 (ERK7) (  Abe 
et al., 1999  ), and the mitogen-activated protein kinases (MAPK) 
ERK1/2 (  Monje et al., 2003  ) and p38 (  Tanos et al., 2005  ). 
  Importantly, c-Fos transcriptional activity is modulated through 
reversible phosphorylation by some of these kinases, including 
ERK1/2 (  Hunter and Karin, 1992  ;   Hill and Treisman, 1995  ;   Monje 
et al., 2003  ). Phosphorylation of c-Fos by ERK1 and RSK oc-
curs soon after serum stimulation (  Chen et al., 1993  ,   1996  ). 
Moreover, a docking site for ERK in c-Fos facilitates its sequen-
tial phosphorylation in multiple C-terminal sites upon prolonged 
ERK activation (  Murphy et al., 2002  ). The binding of growth 
factors, differentiation stimuli, and cytokines to cell surface re-
ceptors promotes the activation of the small GTPase Ras and 
dual phosphorylation (activation) of ERKs. Active ERK1 and 
ERK2 translocate into the nucleus, where they phosphorylate sev-
eral transcriptional regulators (e.g., c-Fos) that cause a rapid in-
duction of immediate early genes (  Sharrocks, 2001  ). 
S
equestration of c-Fos at the nuclear envelope (NE) 
through interaction with A-type lamins suppresses 
AP-1  –  dependent transcription. We show here that 
c-Fos accumulation within the extraction-resistant nu-
clear fraction (ERNF) and its interaction with lamin A are 
reduced and enhanced by gain-of and loss-of ERK1/2 
activity, respectively. Moreover, hindering ERK1/2-
dependent phosphorylation of c-Fos attenuates its re-
lease from the ERNF induced by serum and promotes its 
interaction with lamin A. Accordingly, serum stimula-
tion rapidly releases preexisting c-Fos from the NE via 
ERK1/2-dependent phosphorylation, leading to a fast 
activation of AP-1 before de novo c-Fos synthesis. More-
over, lamin A  –  null cells exhibit increased AP-1 activity 
and reduced levels of c-Fos phosphorylation. We also 
ﬁ  nd that active ERK1/2 interacts with lamin A and co-
localizes with c-Fos and A-type lamins at the NE. Thus, 
NE-bound ERK1/2 functions as a molecular switch for 
rapid mitogen-dependent AP-1 activation through phos-
phorylation-induced release of preexisting c-Fos from its 
inhibitory interaction with lamin A/C.
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  Results 
  c-Fos accumulation at the extraction-
resistant nuclear fraction is regulated by 
lamin A/C expression and the level of c-Fos 
phosphorylation 
 We  fi rst examined by Western blot the consequences of altering 
lamin A/C expression on the amount of c-Fos within the soluble 
nuclear fraction (SNF) and extraction-resistant nuclear fraction 
(ERNF) of cultured cells. Lamin A/C  –  null mouse embryonic fi  -
broblasts (MEFs) exhibited decreased ERNF-associated and in-
creased SNF-associated level of c-Fos compared with wild-type 
controls (  Fig. 1 A  ), and ectopically expressed CFP-Lamin A in-
creased the presence of both endogenous c-Fos and recombi-
nant YFP  –  c-Fos within the ERNF of HEK293 and COS7 cells, 
respectively (  Fig. 1 B  ).  
[ID]FIG1[/ID] Consistent with our previous confocal 
microscopy studies in MEFs (  Ivorra et al., 2006  ), CFP-lamin A 
overexpression in NIH-3T3 and COS7 cells recruited YFP  –  c-Fos 
  In addition to fulfi  lling structural functions at the nuclear en-
velope (NE), A-type lamins (lamin A and C) play important roles 
in the control of gene expression via their interaction with histones, 
transcription factors (e.g., SREBP1, MOK2, BAF, GCL, Mel18, 
and c-Fos), and cell cycle regulators (e.g., the retinoblastoma pro-
tein [pRb] and cyclin D3) (  Taniura et al., 1995  ;   Gruenbaum et al., 
2005  ;   Mariappan and Parnaik, 2005  ;   Broers et al., 2006  ;   Heessen 
and Fornerod, 2007  ;   Vlcek and Foisner, 2007  ). We have recently 
shown that lamin A/C  –  dependent sequestration of c-Fos at the 
NE reduces AP-1 DNA-binding activity and cellular proliferation 
( Ivorra et al., 2006 ). However, the molecular mechanisms controll-
ing this interaction remain unknown. Here we tested the hypothesis 
that ERK1/2 is a critical regulator of the interaction between lamin 
A/C and c-Fos. We show that active ERK1/2 directly interacts with 
lamin A and colocalizes with c-Fos at the NE. Therein, mitogen-
induced ERK1/2-mediated phosphorylation of c-Fos releases it 
from the inhibitory interaction with lamin A/C before de novo syn-
thesis of c-Fos, thus allowing a rapid induction of AP-1 activity. 
  Figure 1.       Hypophosphorylated c-Fos preferentially accumulates in the ERNF.   Western blot analysis of whole cell extracts and subcellular fractions. 
Numbers on the side of the blots indicate molecular weight (in kD). (A) Wild-type and lamin A/C  –  null MEFs were starved for 24 h and stimulated for 
90 min with PDGF-BB. Anti-Sp1 and anti-NUP50 antibodies showed equal protein loading and the absence of cross-contamination for the subnuclear frac-
tionation protocol used. (B) HEK293 cells were transfected with pcDNA3 (control) or CFP-Lamin A, starved for 24 h, and stimulated for 90 min with 10% 
FBS. Asynchronously growing COS7 cells were cotransfected with YFP  –  c-Fos and either pcDNA3 (control) or CFP-Lamin A. The used antibodies and the 
detected proteins are indicated on the left and right, respectively. (C) Serum-stimulated NIH-3T3 cells. Arrows point to c-Fos species with different degree 
of phosphorylation. (D) SNF of serum-stimulated NIH-3T3 cells. Lysates were prepared in buffer with or without protease and phosphatase inhibitors and 
treated with alkaline phosphatase when indicated. (E) SNF and whole cell extract of starvation-synchronized NIH-3T3 cells stimulated with serum for the 
indicated time and treated with the proteasome inhibitor MG132 when indicated. (F) SNF of serum-stimulated NIH-3T3 cells preincubated with the ERK1/2 
pathway inhibitor U0126 when indicated.     655 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
Compared with serum-starved cells, the level of c-Fos protein 
was up-regulated in cultures stimulated for 90 min, which was 
markedly reduced after 180 min of serum stimulation (  Fig. 1 E  , 
lanes 1  –  3). Moreover, treatment with the proteasome inhibitor 
MG132 abrogated c-Fos down-regulation at 180 min after serum 
stimulation (  Fig. 1 E  , lane 5 vs. 3). These fi  ndings are in agree-
ment with the concept that mitogen stimulation leads to de novo 
c-Fos expression, which then undergoes proteasome-dependent 
degradation (  Bossis et al., 2003  ;   Ito et al., 2005  ). In line with 
previous studies (  Monje et al., 2003  ), we found that preincuba-
tion of serum-starved cells with the ERK1/2 inhibitor U0126 
greatly reduces c-Fos level in cells stimulated with serum for 90 
min (  Fig. 1 F  ). Therefore, to circumvent the possible infl  uence 
of ERK1/2 inhibitors on c-Fos synthesis and/or degradation, the 
effects of U0126 and PD98059 on c-Fos expression and sub-
nuclear localization was investigated using the protocol schema-
tized in  Fig. 2 A . In brief, mitogen-depleted cells were stimulated 
with serum for 150 min in the presence of MG132 to avoid pro-
teasome-dependent degradation of c-Fos. To prevent further 
protein synthesis after reaching a high level of c-Fos expression, 
cycloheximide was added at 90 min. Finally, U0126 or PD98059 
was added at 100 min after serum stimulation. In agreement 
with the results of   Fig. 1 C  , the ERNF and SNF of NIH-3T3 cells 
to the perinuclear rim (unpublished data). These results demon-
strated that c-Fos accumulation at the NE and ERNF is depen-
dent on lamin A/C expression. 
  We next sought to investigate the molecular mechanisms 
regulating the association of c-Fos with the NE. Although two 
main species of c-Fos with different electrophoretic mobilities 
were detected in the SNF of NIH-3T3 cells restimulated with se-
rum after a period of starvation, the faster migrating band predomi-
nated in the ERNF (  Fig. 1 C  ). Incubation of the SNF with alkaline 
phosphatase increased c-Fos mobility (  Fig. 1 D  , lane 1 vs. 2), but 
this change was not seen in the presence of phosphatase and 
protease inhibitors (  Fig. 1 D  , lanes 3 and 4). Thus, the SNF of 
  serum-stimulated cells accumulates hyperphosphorylated and 
hypophosphorylated c-Fos, whereas the ERNF predominantly ac-
cumulates the hypophosphorylated form of c-Fos. These results 
suggested that mitogen-dependent phosphorylation of c-Fos fa-
cilitates its release from the NE. 
  We then focused our attention on ERK1/2-dependent sig-
naling, the main transduction pathway implicated in the rapid 
and transient phosphorylation and subsequent activation of c-Fos 
elicited by mitogens (  Monje et al. 2003  ). As expected, Western 
blot analysis of the SNF of NIH-3T3 cells revealed the activation 
(phosphorylation) of ERK1/2 after serum stimulation (  Fig. 1 E  ). 
  Figure 2.       ERK1/2 inhibition increases the amount of c-Fos associated to the ERNF  . (A) Scheme of the protocol used to study the effects of post-
transductional modiﬁ  cations of c-Fos on its accumulation within the ERNF and SNF, and on its interaction with lamin A. Cultures were serum starved 
for 24 h and then stimulated for 150 min with serum (U20S and COS7 cells: 10% FBS; NIH-3T3 cells: 10% NBS) to activate the MAPK pathway 
and to induce de novo c-Fos protein synthesis. The proteasome inhibitor MG132 (25   μ  M) was present throughout serum stimulation to prevent 
c-Fos degradation. After c-Fos induction (    90 min), protein synthesis was inhibited with cycloheximide (10   μ  g/ml). When indicated, the ERK1/2 
inhibitors PD98059 (20   μ  M) and U0126 (10   μ  M) were added for the last 50 min (B) Western blot analysis of the SNF and ERNF of NIH-3T3 cells 
treated as described above. Numbers on the side of the blots indicate molecular weight (in kD). Arrows point to c-Fos species with different degree 
of phosphorylation.     JCB • VOLUME 183 • NUMBER 4 • 2008  656
c-Fos or YFP (as negative control).   Fig. 3, A  –  C   show represen-
tative images and intensity line profi  les. In agreement with our 
previous FRET studies (  Ivorra et al., 2006  ), cells cotransfected 
with CFP-lamin A/YFP  –  c-Fos exhibited a signifi  cant increase 
in FRET effi  ciency in the perinuclear rim compared with nega-
tive controls (  Fig. 3 D  ). Addition of U0126 inhibited ERK1/2, 
as revealed by reduced ERK1/2 phosphorylation in the SNF 
(  Fig. 3 E  ), and signifi  cantly increased FRET effi  ciency in cells 
cotransfected with CFP-lamin A/YFP but not with CFP-lamin 
A/YFP (  Fig. 3 D  ).  
[ID]FIG3[/ID] These results indicated that ERK1/2 inhibi-
tion increases the level of c-Fos/lamin A interaction in vivo. 
  Constitutive ERK1/2 activation reduces 
the presence of c-Fos in the ERNF 
  Consistent with the results of   Fig. 2 B  , treatment of U2OS cells 
with U0126 reduced the amount of hyperphosphorylated c-Fos 
in the SNF and ERNF fractions, and increased the amount of 
hypophosphorylated c-Fos within the ERNF (  Fig. 4 A  , lane 
1 vs. 2). Overexpression of MEKE, a constitutively active form 
of MEK1, markedly augmented ERK1/2 phosphorylation in 
the SNF compared with controls transfected with empty vector 
(  Fig. 4 A  , pERK1/2, lane 2 vs. 3). This effect coincided with di-
minished retention of c-Fos in the ERNF, especially of the hy-
perphosphorylated species, which appeared to accumulate in 
the SNF (  Fig. 4 A  , lane 2 vs. 3).  
[ID]FIG4[/ID] Thus, constitutive activation of 
ERK1/2 reduces the amount of ERNF-associated c-Fos. 
manipulated as described above predominantly contained the 
fastest migrating hypophosphorylated and the two migrating 
forms of c-Fos, respectively ( Fig. 2 B , ERNF: lanes 1 and 3; SNF: 
lanes 5 and 7).  
[ID]FIG2[/ID] Treatment with either PD98059 or U0126 inhib-
ited ERK1/2 activation, as revealed by the reduced amount 
of phosphorylated ERK1/2 (pERK1/2) in the SNF (  Fig. 2 B  , 
PD98059: lane 5 vs. 6; U0126: lane 7 vs. 8), and caused the accu-
mulation of hypophosphorylated c-Fos both in the ERNF (  Fig. 2 B  , 
PD98059: lane 1 vs. 2; U0126: lane 3 vs. 4) and SNF (  Fig. 2 B  , 
PD98059: lane 5 vs. 6; U0126: lane 7 vs. 8). The pattern of ex-
pression of Sp1 and nucleoporin-50 + Npap60 (NUP50) suggested 
the absence of cross-contamination in these studies (  Fig. 2 B  ). 
The results presented thus far indicated that the amount of c-Fos 
in the ERNF and perinuclear rim is regulated by the level of lamin 
A/C expression. They also suggested that inhibition of ERK1/2 
activity reduces the extent of c-Fos phosphorylation and promotes 
its accumulation within the ERNF. 
  ERK1/2 inhibition increases the interaction 
of c-Fos with lamin A in vivo 
 We next performed fl  uorescence resonance energy transfer (FRET) 
confocal microscopy studies to examine the in vivo interaction 
between c-Fos and lamin A. FRET effi  ciency determined as 
the increment in CFP fl  uorescence after YFP photobleaching 
( Kenworthy,  2001 )  was  quantifi  ed in asynchronously growing 
COS7 cells cotransfected with CFP-lamin A and either YPF  – 
  Figure 3.       ERK1/2 inhibition increases the interaction between c-Fos and lamin A in vivo.   FRET was measured in NIH-3T3 cells using the acceptor photo-
bleaching method. Cells were transiently cotransfected with CFP-lamin A and either YFP (negative control) or YFP  –  c-Fos. Transfected cells were maintained 
in 10% NBS for 24 h and U0126 was added for the last 50 min when indicated. (A) Representative images of one YPF  –  c-Fos/CFP-lamin A  –  transfected 
U0126-treated cell before and after YFP photobleaching. The two perinuclear regions marked with white squares enlarged in B illustrate increased CFP 
ﬂ  uorescence after photobleaching. (C) Fluorescence line proﬁ  le analysis of CFP-lamin A intensity throughout the entire perinuclear rim shown in A before 
(green) and after (red) photobleaching of YFP. (D) Quantiﬁ  cation of protein  –  protein interactions calculated as the percentage of CFP ﬂ  uorescence increment 
after photobleaching in 20  –  30 cells from three independent experiments. (E) Western blot analysis of the SNF of cells maintained in 10% NBS treated or 
not with U0126. Numbers on the side of the blots indicate molecular weight (in kD).     657 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
ERK1/2 activation is a physiological mechanism for releasing 
c-Fos from the ERNF. 
  To directly examine whether ERK1/2-dependent phos-
phorylation of c-Fos affects its affi  nity for lamin A, we per-
formed in vitro pull-down assays using a GST-lamin A fusion 
protein containing amino acids 37  –  244 of rat lamin A, which 
interacts with recombinant c-Fos (  Ivorra et al., 2006  ). GST-
 lamin  A  specifi  cally interacted with the endogenous c-Fos pro-
tein present in extracts from serum-stimulated NIH-3T3 cells 
(  Fig. 5 A  , lane 3 vs. 4).  
[ID]FIG5[/ID] Moreover, the amount of GST-lamin A  –
  bound c-Fos was greatly increased upon treatment of cells with 
PD98059 (  Fig. 5 B  , lane 3 vs. 4). We also compared the binding 
of GST-lamin A to c-Fos-wt and c-Fos-m, which were ectopi-
cally expressed in serum-stimulated U2OS cells. Examination 
of input samples suggested the presence of phosphorylation 
  activity in these cultures because c-Fos-wt exhibited slower 
electrophoretic mobility than c-Fos-m (  Fig. 5 C  , lane 2 vs. 3). 
Moreover, GST-lamin A interacted more effi  ciently with c-Fos-m 
compared with c-Fos-wt (  Fig. 5 C  , lane 5 vs. 6). These re-
sults suggested that the interaction of c-Fos with lamin A is 
  facilitated by inhibiting ERK1/2-mediated phosphorylation of 
c-Fos, either by mutational blockade of ERK1/2 phosphory-
lation sites in c-Fos or by pharmacological inhibition of the 
ERK1/2 pathway. 
  Mutations that hinder ERK1/2-dependent 
phosphorylation of c-Fos impair its release 
from the ERNF and enhance its interaction 
with lamin A 
  We next sought to assess whether physiological levels of 
ERK1/2 activation can release c-Fos from the ERNF. To this 
end, we investigated in U2OS cells the subnuclear localiza-
tion of ectopically expressed wild-type c-Fos (c-Fos-wt) and 
c-Fos-m, a mutant in which four residues that undergo ERK1/2-
dependent phosphorylation are rendered unphosphorylatable 
(T232A, T325A, T331A, S374A) (  Monje et al., 2003  ) (see 
scheme in   Fig. 4 B  ). The level of serum-dependent ERK1/2 
activation was similar in cells transfected with c-Fos-wt and 
c-Fos-m, as revealed by comparable increases in the amount 
of pERK1/2 in the SNF (  Fig. 4 B  , c-Fos-wt: lane 2 vs. 3; 
c-Fos-m: lane 4 vs. 5). Serum-inducible ERK1/2 activation 
coincided with reduced amount of ERNF-associated c-Fos-wt 
(  Fig. 4 B  , lane 2 vs. 3), but this effect was weaker for c-Fos-m 
(  Fig. 4 B  , lane 4 vs. 5). The mobility shift of mutated c-Fos-m 
upon stimulation is likely due to ERK1/2-dependent phos-
phorylation at site(s) that is(are) not important for lamin A/C 
association and possibly for c-Fos activation, per se (e.g., S21, 
S32, S70, S133; see scheme in   Fig. 4 B  ). These fi  ndings sug-
gested that serum-inducible phosphorylation of c-Fos through 
  Figure 4.       ERK1/2 constitutive activation reduces c-Fos accumulation in the ERNF and mutations that hinder ERK1/2-dependent phosphorylation of c-Fos 
impair its release from the ERNF.   The SNF and ERNF of U2OS cells were analyzed by Western blot. Numbers on the side of the blots indicate molecular 
weight (in kD). (A) Cells were transfected with pcDNA3 or with a plasmid encoding MEKE, a constitutively active form of MEK1. 1 d after transfection, 
cells were subjected to the protocol shown in   Fig. 2 A  . (B) Scheme of the potentially phosphorylatable residues of wild-type c-Fos (c-Fos-wt) and c-Fos-m, 
which contains the following amino acid substitutions in residues phosphorylated by ERK1/2: T232A, T325A, T331A, S374A. Cells were transfected with 
a plasmid encoding c-Fos-wt or c-Fos-m. 1 d after transfection, cells were starved for 24 h and serum stimulated for 30 min when indicated. Of note, four 
putative sites for ERK1/2-dependent phosphorylation are intact in c-Fos-m (S21, S32, S70, S133).     JCB • VOLUME 183 • NUMBER 4 • 2008  658
increase in AP-1 DNA-binding activity in the SNF (  Fig. 6 D  , 
lanes 2 vs. 3), which was not affected by inhibiting de novo pro-
tein synthesis (lanes 4 vs. 5) but was blunted upon pharmaco-
logical inhibition of ERK1/2 (lanes 6 vs. 7). AP-1 DNA-binding 
activity was further increased after 90 min of serum stimulation 
(  Fig. 6 D  , lane 8) through a mechanism requiring both de novo 
protein synthesis (lane 9) and ERK1/2 activation (lane 10). Sp1 
DNA-binding activity remained essentially unaffected by all the 
above manipulations (  Fig. 6 E  ). 
  Lamin A/C inhibits AP-1 activity and 
facilitates c-Fos phosphorylation 
  We have previously shown that lamin A/C overexpression sup-
presses AP-1 DNA binding and transcriptional activity (  Ivorra 
et al., 2006  ). To gain further insight into the role of A-type lam-
ins on AP-1 function, we compared the kinetics of AP-1 DNA 
binding and transcriptional activity in wild-type versus lamin 
A/C  –  null MEFs. Consistent with the results in NIH-3T3 cells 
(  Fig. 6 D  ), EMSAs demonstrated a progressive increase in AP-1 
DNA-binding activity in wild-type MEFs stimulated with se-
rum for 15 and 90 min (  Fig. 7 A  ).  
[ID]FIG7[/ID] Compared with wild-type con-
trols, two dramatic alterations in AP-1 DNA-binding activity 
  Serum-dependent activation of ERK1/2 
rapidly releases preexisting c-Fos 
from the ERNF and induces AP-1 
DNA-binding activity 
  The results presented thus far suggested that serum-inducible 
ERK1/2-dependent phosphorylation of c-Fos releases is from 
the inhibitory interaction with A-type lamins. To assess whether 
this process might be physiologically relevant, we investigated 
the effects of serum stimulation on the subnuclear localiza-
tion of endogenous c-Fos and on AP-1 DNA-binding activ-
ity. In agreement with numerous studies, Western blot analysis 
of NIH-3T3 whole cell extracts demonstrated the activation of 
pERK1/2 and up-regulation of c-Fos after 15 and 60 min of se-
rum stimulation, respectively (  Fig. 6 A  ). Coinciding with the 
peak of ERK1/2, c-Fos expression diminished in the ERNF and 
accumulated within the SNF (  Fig. 6 B  ).  
[ID]FIG6[/ID] The presence of c-Fos 
in the NE and its release after 15 min of serum stimulation was 
also observed in double immunofl  uorescence confocal micros-
copy experiments with U2OS cells submitted to in situ extraction 
of soluble cytoplasmic and nucleoplasmic proteins (  Fig. 6 C  ). 
Moreover, electrophoretic mobility shift assays (EMSA) revealed 
that 15 min of serum induction causes in NIH-3T3 cells a rapid 
  Figure 5.       ERK1/2-dependent phosphorylation of c-Fos affects its interaction with lamin A.   GST-lamin A fusion protein containing amino acid residues 
37  –  244 of rat lamin A was tested for its interaction with either endogenous c-Fos present in the SNF of NIH-3T3 cells (A and B) or with c-Fos-wt or c-Fos-m 
ectopically expressed in U2OS cells (C). Nuclear extracts were incubated with GST proteins and 1/20 of the reaction mixture was examined by Western 
blot (INPUT). The rest was precipitated with gluthatione-Sepharose 4B, washed and analyzed by Western blot. The used antibodies and the detected pro-
teins are indicated. Numbers on the side of the blots indicate molecular weight (in kD). In B, cells were subjected to the protocol schematized in   Fig. 2 A  . 
In C, cells were transfected with c-Fos-wt or c-Fos-m. 24 h after transfection, cells were starved for 24 h and stimulated with serum for 30 min.     659 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
  Figure 6.       Serum-inducible ERK1/2 activation correlates with the release of preexisting c-Fos from the ERNF and causes a rapid induction of AP-1 DNA-
binding activity.   (A and B) NIH-3T3 cells were starved for 24 h and stimulated with 10% NBS for the indicated times. Whole cell extracts (A), or SNF and 
ERNF (B) were analyzed by Western blot. Of note, the amount of protein analyzed in the blots of B was     14 times higher than in A. Numbers on the 
side of the blots indicate molecular weight (in kD). (C) Double immunoﬂ  uorescence of c-Fos and lamin A/C in U2OS cells. Top images: Asynchronously 
growing control cells. Middle and bottom images: Starved and serum-stimulated cells in situ extracted and treated with DNase. Images in the right column 
show 3D representation of c-Fos signal intensity in lamin A/C  –  containing perinuclear rim. Graph shows the total intensity of c-Fos signal per total lamin 
A/C  –  containing perinuclear area of in situ extracted cells (  n   = 30 cells of each condition). (D and E) NIH 3T3 were starved for 24 h and stimulated with 
10% NBS for the indicated times. When indicated, cycloheximide (CHX, 10   μ  g/ml) or U0126 (10   μ  M) was added 1 h before serum stimulation. EMSA 
was performed using 10 fmol of a consensus AP-1 (D) or Sp1 (E) radiolabeled probe and SNF (5   μ  g total protein). The graphs show the quantiﬁ  cation of 
DNA-binding activity as assessed by densitometric analysis. Reactions in lanes 11 and 22 contained a 50-fold molar excess of competitor (unlabeled AP-1 
or Sp1 consensus oligonucleotide, respectively).     JCB • VOLUME 183 • NUMBER 4 • 2008  660
  Figure 7.       Lamin A/C inhibits AP-1 activity and facilitates c-Fos phosphorylation.   (A) EMSA using 10 fmol of a consensus AP-1 or Sp1 radiolabeled 
probe and SNF (15   μ  g total protein) from wild-type and lamin A/C  –  null MEFs starved for 48 h and stimulated with 10% FBS for different times. 
Graph shows the quantiﬁ  cation of AP-1 DNA-binding activity after normalization with Sp1 DNA-binding activity as assessed by densitometric analysis. 
(B) Luciferase activity in extracts from wild-type and lamin A/C  –  null MEFs cotransfected with the AP-1  –  responsive coll73-luciferase and pGL4-Renilla 
luciferase reporters (  n   = 12). (C) Luciferase activity in extracts from U2OS cells cotransfected with coll73-luciferase and either miRNA-control/GFP or 
miRNA-LMNA/GFP (  n   = 12). The Western blot and the confocal microscopy images demonstrate efﬁ  cient lamin A/C silencing by miRNA-LMNA/GFP. 
(D) Western blot analysis of whole cell extracts from starved and restimulated wild-type and lamin A/C  –  null MEFs. Numbers on the side of the blots 
indicate molecular weight (in kD).     
were observed in lamin A/C  –  null MEFs: a marked induction 
under serum starvation, and a lack of activation at 15 min of se-
rum restimulation; in contrast, Sp1 DNA-binding activity re-
mained largely unaffected upon lamin A/C ablation (  Fig. 7 A  ). 
As shown in   Fig. 7 B  , lamin A/C  –  null MEFs exhibited signifi  -
cantly higher AP-1-dependent transcriptional activity, as revealed 
in transient transfection assays with the AP-1  –  responsive coll73-
luciferase reporter gene. Silencing lamin A/C expression with 
miRNA also increased activity of coll73-luciferase in U2OS 
cells (  Fig. 7 C  ). Moreover, we found that both the maximum 
level of c-Fos protein and the relative abundance of its hyper-
phosphorylated form were reduced in serum-stimulated lamin 
A/C compared with wild-type MEFs (  Fig. 7 D  ). 
  ERK1/2 interacts with lamin A in vitro 
and in vivo 
  We next performed immunoprecipitation-coupled Western blot 
analysis to test whether ERK1/2 could directly interact with 
lamin A/C. Anti-lamin A serum, but not preimmune serum, co-
precipitated lamin A and ERK1/2 from asynchronously grow-
ing HEK293 cells (  Fig. 8 A  ). Moreover, anti-ERK2, but not 
preimmune serum, coprecipitated lamin A and ERK1/2 (  Fig. 8 A  ). 
 
[ID]FIG8 [/ID] Of note, the anti-lamin A serum precipitated phosphorylated 
ERK1/2 (  Fig. 8 A  ), suggesting that active ERK1/2 can interact 
with lamin A/C in vivo. In contrast, lamin A and the transcrip-
tion factor Sp1 did not coimmunoprecipitate, whereas Sp1-
ERK2 complexes could be immunoprecipitated with either 
anti-Sp1 or anti-ERK2 antibodies, in agreement with previous 
studies (  Milanini-Mongiat et al., 2002  ). 
  GST pull-down assays revealed that amino acids 247  –  355 
of lamin A/C, but not the fragments spanning amino acids 37  –
  244 and 356  –  571, associated to ERK1/2 from HEK293 cells 
(  Fig. 8 C  ). We extended these studies by determining the region 
in ERK2 responsible for binding to lamin A/C. In particular, 
we tested two interaction   “  hot spots  ”  : the CD domain and the 
Insert region (  Robinson et al., 1998  ). We found that mutations 
D316,319A that abrogate interactions mediated through the CD 
domain (  Tanoue et al., 2000  ) did not affect the binding of ERK2 
to lamin A/C. Conversely, an ERK2 Insert region deletion 
 mutant  (   241-272) (  Whitehurst et al., 2004  ) and point mutants 
within this region, Y261N and S264Y, were impaired in their 
association with lamin A/C (  Fig. 8 D  ). 661 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
  Discussion 
  We recently reported that sequestration of c-Fos at the NE 
through its interaction with A-type lamins is a mechanism of 
suppressing AP-1  –  dependent transcription in mammalian cells 
(  Ivorra et al., 2006  ). In the present study we provide evidence 
that disruption of lamin A/C constitutively activates AP-1  –
    dependent DNA-binding and transcriptional activity. We also 
demonstrate that the interaction of c-Fos with lamin A/C is a 
reversible process controlled by mitogenic stimuli through 
ERK1/2-dependent signaling. First, we show that mitogen-
  dependent ERK1/2-mediated phosphorylation of c-Fos releases 
it from the inhibitory interaction with lamin A/C, allowing the 
rapid activation of AP-1 before de novo c-Fos protein synthesis. 
Second, we demonstrate that phosphorylated (active) ERK1/2 
can interact with lamin A/C in vitro and in vivo, and colocalize 
with c-Fos at the NE. This scaffold role of lamin A/C appears to 
  Lamin A/C, ERK1/2, and c-Fos colocalize 
at the mammalian NE 
  Double confocal immunofl  uorescence microscopy revealed 
areas of colocalization between endogenous ERK2 and lamin 
A/C at the perinuclear rim in COS7, U2OS, and HEK293 cells 
(  Fig. 9 A  , and unpublished data). Perinuclear colocalization of 
lamin A/C  –  ERK2 was also manifest after in situ extraction plus 
DNase treatment (  Fig. 9 B  ). In contrast, perinuclear localization 
of Sp1 was negligible under the same experimental conditions 
(  Fig. 9 B  ).  
[ID]FIG9[/ID] We next examined the possible colocalization of 
c-Fos and ERK1/2 at the NE. Lamin A/C entirely colocalized 
with lamin B at the perinuclear rim (  Fig. 9 C  ); therefore, NE-
  associated lamin A/C could be unequivocally recognized by local-
izing lamin B expression. Analysis of asynchronously growing 
U2OS cells co-immunostained for c-Fos, ERK2, and lamin B 
revealed partial colocalization of these proteins in the peri-
nuclear rim (  Fig. 9 D  ). 
  Figure 8.       ERK1/2 interacts with lamin A in vitro and in vivo.   (A, B) Lysates from HEK293 cells (stimulated 5 min with EGF after serum deprivation) 
were immunoprecipitated with either anti-lamin A/C (sc-20680), anti-ERK2 or anti-Sp1 antibodies. Preimmune serum was used as control. Both the 
input and the whole immunoprecipitated material were subjected to Western blot analysis using anti-ERK2, anti-pERK1/2, anti-Sp1 and anti-lamin 
A/C (sc-20680) antibodies as indicated. (C) GST-lamin A fusion proteins containing amino acid residues 37  –  244, 243  –  388 or 453  –  571 of rat 
lamin A were tested for their interaction with endogenous ERK1/2 from whole HEK293 cell extracts. Approximately 90% of the reaction mixture 
was precipitated with gluthatione-Sepharose 4B, washed and analyzed by Western blot. (D) Lysates from HEK293 cells overexpressing FLAG-tagged 
ERK2 (wild-type and several mutants) were immunoprecipitated with an anti-FLAG antibody. Both the input and the whole immunoprecipitated 
material were subjected to Western blot analysis using anti-FLAG and anti-lamin A/C (sc-20680) antibodies. In the scheme in C and D, (+) and 
(−) indicate positive and negative interactions, respectively. NLS: Nuclear localization signal. Numbers on the side of the blots indicate molecular 
weights (in kD).     JCB • VOLUME 183 • NUMBER 4 • 2008  662
after stimulation (  Kruijer et al., 1984  ;   Kerr et al., 1988  ;   Monje 
et al., 2003  ;   Ivorra et al., 2006  ;   Murphy and Blenis, 2006  ). 
In line with this notion, we observed maximum c-Fos protein ex-
pression at 60 – 90 min after serum stimulation ( Fig. 1 E ,  Fig. 6 A ), 
coinciding with a peak of AP-1 DNA-binding activity that could 
be attenuated by inhibitors of either protein synthesis or ERK1/2 
activity (  Fig. 6 D  ). Our novel observation is the induction of 
AP-1 DNA-binding activity as early as 15 min after serum ad-
dition concomitantly with maximum ERK1/2 activity and the 
release of c-Fos from the ERNF to the nucleoplasm in a manner 
dependent on ERK1/2 activation but independent of de novo 
facilitate the phosphorylation of c-Fos elicited by ERK1/2 in 
cells stimulated with serum. 
  It is generally accepted that mitogen-dependent activation 
of ERK1/2 in fi  broblasts is a biphasic process consisting of a 
rapid and strong burst of kinase activity peaking at 5  –  15 min, 
followed by a second wave of lower activity that persists through-
out the G1 phase of the cell cycle (  Kahan et al., 1992  ;   Meloche 
et al., 1992  ;   Meloche, 1995  ). c-Fos is expressed minimally in 
most nongrowing cells as well as during the initial phase of 
  mitogen-induced ERK activation, with a peak of de novo c-Fos 
protein synthesis and AP-1 activation occurring between 1  –  2 h 
  Figure 9.       ERK1/2 and c-Fos partially colocalize at the NE.   Representative images of cells examined by confocal microscopy. (A) ERK2-lamin A/C double 
immunoﬂ  uorescence in COS7 cells. Graph shows a line proﬁ  le illustrating areas of colocalization. (B) Control and in situ  –  extracted plus DNase-treated 
U2OS cells were subjected to ERK2  –  lamin A/C or Sp1  –  lamin A/C double immunoﬂ  uorescence. Images in the right column show 3D representation of 
ERK2 or Sp1 signal intensity in the lamin A/C  –  containing perinuclear rim of control and in situ  –  extracted/DNase-treated cells, and the graph shows the 
total intensity of ERK2 and Sp1 signal per total lamin A/C  –  containing perinuclear area in the in situ  –  extracted/DNase-treated cells (  n   = 30). (C) Double 
lamin A/C  –  lamin B immunoﬂ  uorescence in U2OS cells. The graph shows a line proﬁ  le illustrating nearly total colocalization. (D) ERK2  –  c-Fos  –  lamin B triple 
immunoﬂ  uorescence in U2OS cells (left). Lamin B signal was used to delineate the nuclear envelope (white lines in middle column) to allow the quantiﬁ  cation 
of perinuclear ERK2-c-Fos colocalization (yellow signal) shown in the graph, as determined by analyzing 50 cells.     663 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
from the interaction with A-type lamins (see above). Indeed, 
AP-1  –  dependent DNA-binding and transcriptional activity were 
signifi  cantly higher in lamin A/C  –  null versus wild-type MEFs 
and in U2OS cells in which lamin A/C expression was silenced 
with miRNA (  Fig. 7, A  –  C  ). Our results also suggest that the ef-
fi  ciency of serum-inducible activation (phosphorylation) of the 
small preinduction levels of c-Fos elicited by ERK1/2 is aided 
by their colocalization at the NE (  Fig. 7 D  ). We are currently 
investigating whether ERK1/2  –  lamin A/C complex formation 
may help prolong the activation state of ERK1/2 by maintaining 
these signal transducers in a reservoir out of the reach of solu-
ble nuclear phosphatases. It will be also of interest to examine 
whether A-type lamins serve a scaffolding function only for 
ERK1/2-dependent activation of c-Fos, or whether induction 
of other transcription factors also requires the activity of NE-
  associated signal transducers. 
  The Insert and the CD domains of ERK1/2 are involved in 
protein  –  protein interactions. ERK1/2 substrate docking can be se-
lectively dissociated in vitro by single point mutations without per-
turbing ERK activation or its intrinsic catalytic activity (  Dimitri 
et al., 2005  ). Indeed, mutations affecting the Insert region (   241-
272, Y261N, and S264P) or the CD domain (D316,319A) alter 
the interaction of ERK2 with some substrates (  Tanoue et al., 2000  ; 
  Whitehurst et al., 2004  ;   Casar et al., 2007  ). We have shown here 
that the ERK2  –  lamin A/C interaction requires the Insert domain of 
ERK2 and the coil 2 of lamin A/C. Other proteins such as PEA15 
(  Whitehurst et al., 2004  ) and Mxi2 (  Casar et al., 2007  ) also inter-
act with ERK through the Insert region. The determinant mediat-
ing in this interaction is a   “  reverse D domain  ”  , with a consensus 
sequence R/K-   a -X 3/4 -   b  (where    are Leu, Ile, or Val) ( Callaway 
et al., 2005  ). Notably, the R/K-    a -X 3/4 -   b   motif is present in the 
region of A-type lamins, which we found to intervene in their in-
teraction with ERK1/2 (RIRISL at residues 296  –  301). 
protein synthesis (  Fig. 6  ). Based on these fi  ndings and the ob-
servations that gain-of and loss-of ERK1/2 activity reduces and 
enhances, respectively, c-Fos accumulation within the ERNF 
and its interaction with lamin A, and that regulation of these 
processes is impaired by hindering ERK1/2-dependent phos-
phorylation of c-Fos, we propose the model depicted in   Fig. 10  . 
 
[ID]FIG10[/ID] In serum-deprived cells, sequestration of c-Fos at the NE via its 
interaction with lamin A/C limits transcription of AP-1 target 
genes. Subsequent to mitogen stimulation, lamin A  –  bound ac-
tive ERK1/2 phosphorylates c-Fos and releases it from the 
NE, thus allowing the rapid transcriptional activation of AP-1  –
    responsive genes before de novo c-Fos protein synthesis. This 
mechanism permits the continuous existence in the cell of a cer-
tain level of inactive c-Fos (e.g., in quiescent cells) that can be 
rapidly activated by mitogen stimulation via ERK1/2-dependent 
phosphorylation without requiring de novo protein synthesis. 
 Intracellular compartmentalization through interactions 
among MAPKs and scaffold proteins plays an important role in 
the regulation of signal transduction pathways (  Morrison and 
Davis, 2003 ;  Kolch, 2005 ). For example, active MEK – ERK com-
plexes are retained in the cytoplasm and in sites of focal adhe-
sion through interaction with the transmembrane protein Sef 
(  Torii et al., 2004  ) and paxilin (  Ishibe et al., 2004  ), respectively. 
Moreover, kinase suppressor of Ras 1 (  Muller et al., 2001  ) and 
the complex p14-MEK-partner 1 (  Teis et al., 2002  ;   Pullikuth 
et al., 2005  ) are recruited to the plasma membrane and the en-
dosome, respectively, where they enhance MEK and ERK activity. 
On the other hand, the association between ERKs and structural 
nuclear proteins, such as kinetochores, may serve anchoring pur-
poses (  Shapiro et al., 1998  ). To the best of our knowledge, we 
show here for the fi  rst time that A-type lamins function as a nu-
clear docking platform for EKR1/2, and that NE-bound ERK1/2 
contributes to the rapid activation of AP-1 via releasing c-Fos 
  Figure 10.       Model for the rapid activation of AP1 upon mitogen stimulation.   In serum-deprived cells, the c-Fos protein is expressed at low level predomi-
nantly in a hypophosphorylated state and associated to the NE through its interaction with A-type lamins. Under these conditions, transcription of AP-1 
target genes is off. Upon mitogen stimulation, phosphorylated (active) ERK1/2 bound to lamin A/C phosphorylates c-Fos, causing its release from the NE. 
Hyperphosphorylated nucleoplasmic c-Fos can then heterodimerize with AP-1 family members (e.g., c-Jun), thus allowing the transcriptional activation of 
AP-1  –  responsive genes before de novo c-Fos synthesis.     JCB • VOLUME 183 • NUMBER 4 • 2008  664
2003  ); pCMV-FLAG-ERK2; pCMV-FLAG-ERK2-Y261N; pCMV-FLAG-ERK2-
    241-272; pCMV-FLAG-ERK2-S264P and pCMV-FLAG-ERK2-D316A-D319A 
(  Robinson et al., 2002  ); pCEFL-AU5-c-Fos (c-Fos-wt); and pCEFL-AU5-c-Fos-mut 
(c-Fos-m, which contains the following mutations: T232A, T325A, T331A, 
and S374A; gift from S. Gutkind, National Institutes of Health, MD; see 
  Fig. 4 B  ) (  Monje et al., 2003  ). 
  Cell culture 
  NIH-3T3, COS-7, HEK293, U20S, and HeLa cells were obtained from the 
American Type Culture Collection.   Lmna  -null and littermate wild-type MEFs 
are described elsewhere (  Sullivan et al., 1999  ). Cells maintained in DME 
supplemented with 100 U/ml penicillin, 0.1 mg/ml streptomycin, and 2 
mmol/L   L-  glutamine (Invitrogen) and 10% FBS (or 10% NBS for NIH-3T3 
cells) were incubated at 37  °  C in a 5% CO  2  /95% O  2   atmosphere. Cultures 
were serum starved for 24 h and then stimulated with either 10% FBS, 10% 
NBS, PDGF-BB (20 ng/ml; Sigma-Aldrich), or EGF (100 ng/ml; Sigma-
Aldrich). For ERK1/2 inhibition, PD98059 (20   μ  M; Tocris) or U0126 (10   μ  M; 
Promega) were added before serum stimulation. MG132 and cyclohexi-
mide were from Sigma-Aldrich. When indicated, cells were treated as 
schematized in   Fig. 2 A  . 
  In vitro pull-down assays 
  GST proteins were puriﬁ  ed using glutathione-Sepharose 4B (GE Health-
care) and eluted with 50 mM Tris-Cl (pH 8.0). For the experiments of   Fig. 5  , 
GST proteins and cell lysates from NIH-3T3 cells were incubated in 20 mM 
Hepes (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 
1 mM PMSF supplemented with complete protease inhibitor cocktail (Roche). 
After 16 h of incubation at 4  °  C, glutathione-Sepharose 4B was added to a 
ﬁ  nal concentration of 10% and agitated at 4  °  C for 45 min. The beads 
were collected by centrifugation and washed three times with 20 mM 
Hepes (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 
1 mM PMSF. For the experiments of   Fig. 8 C  , whole cell lysates from 
HEK293 cells were incubated with GST-lamin A bound to glutathione-
  Sepharose 4B beads. After 4 h of incubation at 4  °  C, the beads were col-
lected by centrifugation and washed twice with 1% NP-40/PBS. In all 
cases, pellets were air-dried, resuspended in 2x Laemmli buffer, boiled for 
5 min, and separated onto 12% SDS  –  polyacrylamide gels (SDS-PAGE). 
  Subcellular fractionation, immunoprecipitation, and immunoblot 
experiments 
  Immunoprecipitation and Western blot analysis were performed as previ-
ously described (  Ivorra et al., 2006  ;   Casar et al., 2007  ). Subcellular frac-
tionation was performed as described by Schreiber et al. (  1989  ) with minor 
modiﬁ  cations (  Ivorra et al., 2006  ). In brief, cells were washed with PBS and 
scraped into TEN buffer (150 mM NaCl, 1 mM EDTA, and 40 mM TrisCl at 
pH 7.4). Cells were collected by brief centrifugation in microfuge tubes and 
resuspended in 10 mM Hepes (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM 
EGTA, 1 mM DTT, and 0.5 mM PMSF. After 15 min on ice, Nonidet NP-40 
(Fluka) was added to a ﬁ  nal concentration of 10%, and tubes were vortexed. 
Lysates were centrifuged at 4  °  C in a microfuge set at maximum speed to ob-
tain the soluble cytoplasmic fraction (supernatant) and the nuclear pellet, 
which was resuspended in ice-cold 20 mM Hepes (pH 7.9), 0.4 M NaCl, 
1 mM EDTA, 1 mM EGTA, 1 mM DTT, and 1 mM PMSF, and agitated at 4  °  C 
for 15 min. The nuclear lysate was centrifuged for 45 min at 4  °  C to obtain 
the SNF and the pellet containing the ERNF. 
  In situ nuclear matrix isolation and indirect immunoﬂ  uorescence analysis 
  In situ nuclear matrix isolation was performed as described previously (  Fey 
et al., 1984  ). In brief, cells grown on coverslips were washed in PBS and 
extracted twice in cytoskeleton buffer (CSK: 100 mM NaCl, 300 mM 
sucrose, 10 mM PIPES (pH 6.8), 3 mM MgCl  2  , 0.5% Triton X-100, and 1.2 
mM PMSF) for 10 min at 0  °  C. The resulting soluble fraction was removed. 
Extraction buffer (250 mM ammonium sulfate, 300 mM sucrose, 10 mM 
PIPES (pH 6.8), 3 mM MgCl  2  , 1.2 mM PMSF, and 0.5% Triton X-100) was 
added to the Triton X-100 insoluble structures for 10 min at 0  °  C and the 
cytoskeleton fraction was removed. DNase digestion was performed twice 
in digestion buffer (CSK buffer containing 100   μ  g/ml DNase I and 50 mM 
NaCl) followed by extraction in digestion buffer containing 0.25 M 
(NH  4  )  2  SO  4  . In situ  –   extracted and control cells were ﬁ  xed in 4% formalde-
hyde/PBS and permeabilized with 0.5% Triton X-100. All samples were 
blocked for 5 min with 10 mM glycine (pH 8.5) and 1 h with 5% dry milk 
in 10% FBS, 0.5% BSA, 0.1% Triton X-100, and PBS, followed by an over-
night incubation at 4  °  C with anti-c-Fos (1:100), anti-ERK2 (1:100), or anti-Sp1 
(1:100) antibodies. Samples were then incubated with species-appropriate 
FITC-conjugated secondary antibody. After washes and incubation with 
anti-lamin A/C (1:100; sc-7292) for 1 h at room temperature, specimens 
  In this study, we have focused our attention on how mito-
genic signals regulate the interaction between c-Fos and lamin 
A/C. Further research is required to assess whether additional 
pathophysiological conditions regulate this interaction and the 
underlying molecular mechanisms. Of notable interest in this 
regard are the inherited diseases termed laminopathies, which 
are caused by either mutations in the   LMNA   gene (which en-
codes for A-type lamins) or defective posttranslational process-
ing of prelamin A (  Worman and Bonne, 2007  ). Notably, lamin 
A/C and lamin-associated polypeptides can physically interact 
with histones, chromatin, and transcription factors (e.g., c-Fos, 
SREBP1, MOK2, BAF, GCL, Mel18), suggesting that altered 
gene expression contributes to the pathogenesis of laminopa-
thies (  Taniura et al., 1995  ;   Gruenbaum et al., 2005  ;   Broers et al., 
2006  ;   Heessen and Fornerod, 2007  ;   Vlcek and Foisner, 2007  ). 
Indeed, microarray studies using fi  broblast from Hutchinson-
Gilford progeria syndrome patients revealed differential tran-
scription factor expression (  Ly et al., 2000  ;   Csoka et al., 2004  ). 
Moreover, certain pathogenic lamin A mutations cause altera-
tions in the transcription factors MOK2 (  Dreuillet et al., 2008  ) 
and SREBP1 (  Lloyd et al., 2002  ;   Hubner et al., 2006  ) and in the 
cell cycle regulator pRb (  Hubner et al., 2006  ). Interestingly, 
transgenic mice overexpressing either wild-type MEK5 or con-
stitutively active MEK1 exhibit excessive ERK1/2-dependent 
signaling and dilated cardiomyopathy (  Bueno et al., 2000  ;   
Nicol et al., 2001 ), a clinical manifestation of several laminopa-
thies. Moreover, expression of the Emery-Dreifuss muscular 
dystrophy  –  causing H222P  –  lamin A mutant protein in homozy-
gous   lmna  
H222P/H222P   knock-in mice causes in the heart aberrant 
ERK1/2 activity and myopathy, and leads to activation of  several 
MAPKs — including  ERK1/2 — and  downstream  target  genes  in 
cultured cells (  Muchir et al., 2007  ). It is also noteworthy that 
MEK/ERK pathway inhibition improves defective myogenic 
factor expression and differentiation of C2C12 myoblasts 
expressing the Emery-Dreifuss muscular dystrophy  –  causing 
R453W  –  lamin A mutant (  Favreau et al., 2004  ,   2008  ). In the 
light of the aforementioned studies and the fi  ndings reported 
herein, it will be of interest to assess whether pathogenic lamin 
A/C mutants alter the interaction of c-Fos and/or ERK1/2 at the 
NE, and if so, whether they affect the regulation and function of 
AP-1 target genes. 
  Materials and methods 
  Antibodies 
  Primary antibodies directed against c-Fos (sc-52), lamin A/C (sc-7292 in 
  Figs. 1 B, 4, 6 C, 7 C, and 9  ; sc-7293 in   Figs.1 A, C  –  F, 2, 5, 6 A and B, 
and 7 D  ; and sc-20680 in   Fig. 8  ), lamin B (sc-6217), GST (sc-138), ERK2 
(sc-154 and sc-1647 only in   Fig. 9 D  ), pERK1/2 (sc-7383), Sp1 (sc-59-G), 
    -tubulin (sc-8035), anti-FLAG, and HRP-coupled secondary antibodies 
were purchased from Santa Cruz Biotechnology, Inc. Anti-NUP50 and anti-
GFP were from Abcam (ab4005) and Invitrogen (A6455), respectively. 
  Plasmids 
  pECFP-YFP was constructed by inserting YFP into pECFP-C1 (gift from 
J. L  ó  pez-Gim  é  nez, University of Glasgow, Scotland). The following plasmids 
are described elsewhere: pGEX-lamin A (37  –  244), pGEX-lamin A (247  –
  355), and pGEX-lamin A (356  –  571) (gift from T. Ozaki, Chiba Cancer 
Center Research Institute, Japan) (  Ozaki et al., 1994  ); pEYFP-c-Fos and pECFP-
lamin A (  Ivorra et al., 2006  ); pmycCMV-ERK2-MEK1 (  Robinson et al., 1998  ); 
pCDNAI-HA-ERK2 (  Crespo et al., 1994  ); pCEFL-MEKE (  Sanz-Moreno et al., 665 AP-1 REGULATION BY   C  -FOS  –  ERK1/2  –  LAMIN A/C INTERACTIONS   • Gonz  á  lez et al. 
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were washed and incubated with an anti  –  mouse secondary antibody con-
jugated to Alexa 633 (1:300). 
  Phosphatase treatment 
  NIH-3T3 cells were rapidly washed with cold PBS and collected for subcel-
lular fractionation as described above. When indicated, fractionation was 
performed in the absence of phosphatase inhibitors, DTT and PMSF. Ali-
quots of the SNF were incubated in the absence or presence of 1 U of al-
kaline phosphatase (Roche) for 1 h at 37  °  C. Reactions were stopped by 
adding SDS sample buffer and processed for immunoblotting. 
  EMSA 
  Double-stranded oligonucleotides containing the AP-1 (5    -CGCTTGA  T-
GAGTCA  G-3    ; AP-1 site underlined) and the Sp1 (5    -ATTCGATCG  GGGC-
GG  GGCGAGC-3    ; Sp1 site underlined) consensus sites were labeled with 
    [ 
32  P]dATP using polynucleotide kinase (New England Biolabs, Inc.) and pu-
riﬁ  ed on a Sephadex G-50 column. EMSA was performed using the SNF of 
NIH-3T3 cells (5   μ  g total protein) and wild-type and lamin A/C  –  null mice 
MEFs (15   μ  g total protein) as previously described (  Ivorra et al., 2006  ). 
  Confocal microscopy 
  Images were acquired on a laser confocal microscope (TCS/SP2; Leica) 
with a 63x oil immersion objective (NA 1.4). For single lamin A/C (  Fig. 7 C  ) 
and lamin B (  Fig. 7 C  ), double ERK2  –  lamin A/C (  Fig. 9 A  ) and lamin 
B  –  lamin A/C (  Fig. 9 C  ), and triple ERK2  –  c-Fos  –  lamin B immunoﬂ  uores-
cence (  Fig. 9 D  ): cells were ﬁ  xed with 4% PFA/PBS at room temperature 
(RT) on glass coverslips and permeabilized using 0.5% Triton X-100. Sam-
ples were blocked for 5 min with 10 mM glycine (pH 8.5) and 1 h with 5% 
dry milk in 10% FBS, 0.5% BSA, 0.1% Triton X-100, and PBS before an 
overnight incubation at 4  °  C with anti-lamin A/C (1:100; sc-7292) or anti-
lamin B antibody (1:100). In double immunoﬂ  uorescence  experiments, 
samples were incubated with anti-ERK2 (1:100) or anti-lamin B (1:100) 
antibodies for 1 h at room temperature after anti-lamin A/C antibody incu-
bation. For triple immunoﬂ  uorescence, samples were incubated simultane-
ously with anti-c-Fos (1:100) and anti-ERK2 (1:100; sc-1647) antibodies 
after anti-lamin B antibody incubation. Finally, secondary antibodies con-
jugated to Alexa 488, Texas red, and Alexa 633 (Molecular Probes, Inc.) 
were used (1:300). Image quantiﬁ  cation was done using MetaMorph soft-
ware (MDS Analytical Technologies). 
  FRET 
  NIH-3T3 cells were cotransfected with pECFP-lamin A + pEYFP-c-Fos or 
pECFP-Lamin A + EYFP as a negative control (1   μ  g each plasmid) using Li-
pofectamine (Invitrogen). Cotransfection of pECFP-YFP + pcDNA3 (0.5   μ  g 
each) was used as positive control to calibrate the system. Images were ac-
quired on a confocal microscope (TCS/SP2; Leica) with a 63x oil immer-
sion objective (NA 1.4). An argon laser line of 458 nm was used to excite 
CFP (PMT window 465  –  505 nm) and a 514-nm line (20% laser intensity 
for acquisition and 65% for photobleaching) to excite YFP (PMT window: 
525  –  600 nm). Studies were performed in 4% paraformaldehyde-ﬁ  xed 
cells using the acceptor-photobleaching method (  Kenworthy, 2001  ) as pre-
viously described (  Ivorra et al., 2006  ), in which FRET is calculated as the 
relative increase in donor ﬂ  uorescence as a result of the reduction or elimi-
nation of energy transfer when the acceptor is photobleached. Speciﬁ  cally, 
we used the following equation: FRET = (C  after        C  before  )/C  after   x 100, where 
C  before   and C  after   are the total ﬂ  uorescence intensity of the CFP channel be-
fore and after photobleaching, respectively. For negative values, this pa-
rameter was considered 0. 
  Luciferase gene reporter assays 
  Wild-type and lamin A/C  –  null MEFs were transiently transfected with 5   μ  g 
of AP-1  –  dependent coll 73-luciferase reporter plasmid and pGL4-Renilla lu-
ciferase using the calcium phosphate method. U2OS were transfected with 
5   μ  g of coll73-luciferase plus either a plasmid encoding for a miRNA-
  control/GFP or miRNA-LMNA/GFP (BLOCK-IT; Invitrogen). After 48 h in 10% 
FBS, cells were harvested and luciferase activity was measured following the 
manufacturer  ’  s instructions (dual luciferase reporter assay system; Promega). 
Luciferase activity and GFP expression were measured in a luminometer (Vic-
tor). miRNA-transfected cells were also ﬁ  xed in 4% PFA and studied by 
  immunoﬂ  uorescence confocal microscopy, or lysed for Western blot analysis. 
  Statistical analysis 
  Results are reported as mean   ±   SE. In experiments with two groups, differ-
ences were evaluated using a two-tail, unpaired Student  ’  s   t   test. One-way 
ANOVA and Bonferroni  ’  s post hoc test was used for experiments involving 
more than two groups. JCB • VOLUME 183 • NUMBER 4 • 2008  666
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